Artal Group S.A. Synlogic, Inc. Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$5.95 - $14.49 $1.19 Million - $2.9 Million	-200,000 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$7.51 - $14.21 $1.5 Million - $2.84 Million	-200,000 Reduced 50.0%	200,000 $2.84 Million
Q1 2018 May 10, 2018	SELL	$9.38 - $12.12 $1.41 Million - $1.82 Million	-150,000 Reduced 27.27%	400,000 $3.75 Million
Q4 2017 Feb 09, 2018	BUY	$9.15 - $18.9 $5.03 Million - $10.4 Million	550,000	550,000 $5.34 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.